Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Phase II Study of Stimulation of Healthy Sibling Donors with Single-Shot Pegfilgrastim - Update (EUDRACT Nr: 2005-004971-39)

Vladan Vucinic, MD, Sabine Leiblein, PhD, Kristina Schakols, MD, Claudia Nehring, MD, Yvonne Remane, PhD, Madlen Jentzsch, MD, Sebastian Schwind, MD, Wolfram Pönisch, MD, Runa Stiegler, MD, Constanze Kliem, MD, Michael Cross, PhD, Dietger Niederwieser, MD

Blood (2018) 132 (Supplement 1): 2064.

https://doi.org/10.1182/blood-2018-99-118531

Published: 2018

Journal Articles

Reduction of Immunosuppression after Disease-Specific Donor Cell Chimerism Decrease Can Prevent Hematological Relapse Following Allogeneic Stem Cell Transplantation after Non-Myeloablative (NMA) Conditioning — Results of a Prospective Phase II Study. Eudract #: 2007-002420-15

Vladan Vucinic, Saskia Hell, Madlen Jentzsch, MD, Michael Cross, PhD, Sabine Leiblein, Wolfram Pönisch, MD, Georg-Nikolaus Franke, MD, Gerhard Behre, MD, Thoralf Lange, MD, Sebastian Schwind, MD, Dietger Niederwieser, MD

Blood (2017) 130 (Supplement 1): 3230.

https://doi.org/10.1182/blood.V130.Suppl_1.3230.3230

Published: 2017

Journal Articles

Unsupervised Cluster Analysis of Antigen Expression Patterns Identifies Subgroups with Distinct Biological and Clinical Features in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Madlen Jentzsch, MD, Luba Schuhmann, Marius Bill, MDPhD, Sabine Leiblein, PhD, Ulrike Bergmann, Martina Pless, Karoline Schubert, Laura Katharina Schmalbrock, MD, Juliane Grimm, Maria Knyrim, Wolfram Poenisch, MD, Georg-Nikolaus Franke, MD, Vladan Vucinic, MD, Michael Cross, PhD, Gerhard Behre, MD, Dietger Niederwieser, MD, Sebastian Schwind, MD

Blood (2015) 126 (23): 2573.

https://doi.org/10.1182/blood.V126.23.2573.2573

Published: 2015

Journal Articles

Inclusion of Plerixafor Increases the Efficacy of Stem Cell Harvesting in Poorly Mobilizing Patients with Multiple Myeloma and Lymphoma

Madlen Jentzsch, MD, Elena Ruschpler, Sabine Leiblein, PhD, Yvonne Remane, Jan-Phillip Stümpel, MD, Georg-Nikolaus Franke, MD, Simone Heyn, MD, Nadja Jaekel, MD, Susann Schulze, MD, Song-Yau Wang, MD, Wolfram Poenisch, MD, Claudia Nehring, MD, Sebastian Schwind, MD, Dietger Niederwieser, MD, Vladan Vucinic, MD

Blood (2015) 126 (23): 5439.

https://doi.org/10.1182/blood.V126.23.5439.5439

Published: 2015

Journal Articles

Low Level BCR-ABL Mutations and Response to Treatment: A Substudy of the ENEST1st Trial

Georg-Nikolaus Franke, MD, Jacqueline Maier, PhD, Karoline Schubert, Michael Cross, PhD, Sabine Leiblein, Kathrin Wildenberger, Frank Giles, MDMB, Andreas Hochhaus, MD, Oliver Frank, PhD, Dietger Niederwieser, MD, Thoralf Lange, MD

Blood (2014) 124 (21): 3143.

https://doi.org/10.1182/blood.V124.21.3143.3143

Published: 2014

Journal Articles

Reduced Intensity Conditioning Allogeneic Haematopoietic Stem Cell Transplantation - a Treatment Option in Elderly or Comorbid Patients with Acute Lymphatic Leukemia

Vladan Vucinic, MD, Theresa Tumewu, Georg-Nikolaus Franke, MD, Sebastian Schwind, MD, Nadja Jaekel, MD, Simone Heyn, MD, Wolfram Poenisch, MD, Haifa Kathrin Al-Ali, MD, Sabine Leiblein, Rainer Krahl, PhD, Madlen Jentzsch, MD, Gerhard Behre, MD, Dietger Niederwieser, MD

Blood (2014) 124 (21): 5945.

https://doi.org/10.1182/blood.V124.21.5945.5945

Published: 2014

Journal Articles

Successful Stem Cell Mobilization and Autologous Stem Cell Transplantation after Pretreatment Consisting of Bendamustine, Prednisone and Bortezomib (BPV) in 35 Patients with Newly Diagnosed/Untreated Multiple Myeloma

Blood (2014) 124 (21): 5900.

https://doi.org/10.1182/blood.V124.21.5900.5900

Published: 2014

Journal Articles

Low Level BCR-ABL Mutations Below the Detection Limit of Current Standard Screening Techniques Occur Predominantly in the CD34+ Progenitor Cell Compartment in Chronic Phase CML Patients At Diagnosis. A Substudy of the ENEST1st Trial

Jacqueline Maier, Karoline Schubert, Michael Cross, PhD, Sabine Leiblein, Kathrin Wildenberger, Frank Giles, MD, Andreas Hochhaus, MD, Oliver Frank, Dietger Niederwieser, Thoralf Lange

Blood (2012) 120 (21): 1671.

https://doi.org/10.1182/blood.V120.21.1671.1671

Published: 2012

Journal Articles

Impact of Bendamustine Pretreatment on Stem Cell Mobilization and Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Wolfram Pönisch, Julia Wiesler, Ina Wagner, Sabine Leiblein, Elvira Edel, Haifa K. Al-Ali, MD, Vladan Vucinic, Ute Hegenbart, MD, Christiane Heiß, Dietger Niederwieser, MD, Hartmut Goldschmidt, MD

Blood (2011) 118 (21): 1933.

https://doi.org/10.1182/blood.V118.21.1933.1933

Published: 2011

Journal Articles

Adverse Immunologic, Cytogenetic, and Molecular Features of AML in Elderly Patients Could Be Overcome by Allogeneic Hematopoietic Cell Transplantation Following Reduced Intensity Conditioning

Haifa Kathrin Al-Ali, MD, Nadja Jaekel, MD, Rainer Krahl, MD, Claudia Nehring, Cornelia Becker, MD, Leanthe Braunert, MD, Sabine Leiblein, Jeanett Edelmann, Georg Franke, MD, Wolfram Poenisch, Thoralf Lange, MD, Dietger Niederwieser, MD

Blood (2011) 118 (21): 3065.

https://doi.org/10.1182/blood.V118.21.3065.3065

Published: 2011

Journal Articles

Successful Mobilization of Peripheral Blood Stem Cells After Intensive Bendamustine Pre-Treatment In Patients with Multiple Myeloma

Wolfram Pönisch, Julia Wiesler, Sabine Leiblein, Elvira Edel, Haifa K. Al-Ali, Nadezda Basara, MD, Ute Hegenbart, Christiane Heiß, Dietger W Niederwieser, MD, Hartmut Goldschmidt

Blood (2010) 116 (21): 4439.

https://doi.org/10.1182/blood.V116.21.4439.4439

Published: 2010

Journal Articles

The Ratio of Pre-Transplant Serum Ferritin to the Units of Blood Transfused and Not Serum Hepcidin Strongly Correlates with Outcome After Allogeneic Hematopoietic Cell Transplantation In Patients with AML and MDS.

Haifa Kathrin Al-Ali, MD, Nadja Jaekel, MD, Rainer Krahl, MD, Elvira Edel, Claudia Wickenhauser, Mark Westerman, Sabine Leiblein, Uwe Gerd Liebert, Marianne Hehme, Dietger W Niederwieser, MD

Blood (2010) 116 (21): 1307.

https://doi.org/10.1182/blood.V116.21.1307.1307

Published: 2010

Journal Articles

Elevated Serum Hepcidin in Patients with AML Prior to and After Allogeneic Hematopoietic Cell Transplantation Does Not Correlate with Transfusional Body Iron, HFE Genotype or Graft Versus Host Disease and May Protect From Excessive Parenchymal Iron Loading.

Ann-Kathrin Eisfeld, Mark Westerman, PhD, Rainer Krahl, Sabine Leiblein, PhD, Uwe Gerd Liebert, Marianne Hehme, Dietger Niederwieser, MD, Haifa Kathrin Al-Ali, MD

Blood (2009) 114 (22): 4047.

https://doi.org/10.1182/blood.V114.22.4047.4047

Published: 2009

Journal Articles

Mobilization of Allogeneic Peripheral Blood Stem Cells in Family Donors with Single-Dose Pegfilgrastim.

Vladan Vucinic, Nadezda Basara, Runa Stiegler, Kristina Bartsch, Constanze Kliem, Sabine Leiblein, PhD, Dietger Niederwieser

Blood (2009) 114 (22): 2148.

https://doi.org/10.1182/blood.V114.22.2148.2148

Published: 2009

Journal Articles

Factors Influencing Relapse after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Haifa K. Al-Ali, MD, Claudia Nehring, MD, Rainer Krahl, PhD, Cornelia Becker, MD, Sabine Leiblein, PhD, Jeanett Edelmann, PhD, Wolfram Poenisch, MD, Thoralf Lange, MD, Dietger Niederwieser, MD

Blood (2007) 110 (11): 1654.

https://doi.org/10.1182/blood.V110.11.1654.1654

Published: 2007

Journal Articles

Monitoring of Incipient Haematological Relapse by CD34 + Donor Chimerism Determination in Patients with Acute Myelogenous Leukaemia and Myelodysplastic Syndrome after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Low Dose TBI-Based Conditioning Regimens.

Dietger W. Niederwieser, Claudia Nehring, Rainer Krahl, Cornelia Becker, Sabine Leiblein, Jeanett Edelmann, Wolf-Dieter Kortmann, Wolfram Poenisch, Thoralf Lange, Haifa K. Al-Ali

Blood (2007) 110 (11): 5033.

https://doi.org/10.1182/blood.V110.11.5033.5033

Published: 2007

Journal Articles

Donor CD34+ Cell Chimerism at Day 28 and Chronic Graft-Versus-Host Disease (GvHD) but Not High-Risk Cytogenetics Influence Outcome of Allogeneic Hematopoetic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Haifa K. Al-Ali, MD, Claudia Nehring, MD, Rainer Krahl, PhD, Cornelia Becker, MD, Sabine Leiblein, PhD, Jeanett Edelmann, MD, Wolfram Poenisch, MD, Thoralf Lange, MD, Dietger Niederwieser, MD

Blood (2006) 108 (11): 547.

https://doi.org/10.1182/blood.V108.11.547.547

Published: 2006

Journal Articles

CD34 + Donor Chimerism and Wilms Tumor Gene 1 (WT1) Expression Provide an Early Indication of Relapse in Patients with Acute Leukemias and MDS after Hematopoietic Cell Transplantation (HCT) with Reduced-Intensity Conditioning.

Max Hubmann, Ralph Burkhardt, Georg Franke, Michael Cross, Markus Scholz, Sabine Leiblein, Joachim Thiery, Dietger W. Niederwieser, Thoralf Lange

Blood (2006) 108 (11): 548.

https://doi.org/10.1182/blood.V108.11.548.548

Published: 2006

Journal Articles

Loss of Heterozygosity (LOH) for HumACTBP2 (SE33) Is Detected in Philadelphia (Ph)-Positive and Ph-Negative Hematopoietic Cells of Some Patients with Ph-Positive CML.

Haifa K. Al-Ali, MD, Jeanett Edelmann, MD, Sabine Leiblein, PhD, Christel Mueller, Evelin Hennig, Martina Bless, Christina Franke, Dietger W. Niederwieser, MD

Blood (2005) 106 (11): 3286.

https://doi.org/10.1182/blood.V106.11.3286.3286

Published: 2005

Journal Articles

Bendamustine in Combination with Thalidomide and Prednisolone (BPT) in Patients with Refractory or Relapsed Multiple Myeloma after Conventional Chemotherapy: Final Results of a Phase I Study.

Wolfram Poenisch, MD, Marta Rozanski, Sabine Leiblein, PhD, Hartmut Goldschmidt, MD, Franz A. Hoffmann, MD, Thomas Boldt, MD, Robert Rohrberg, MD, Elke Schwalbe, MD, Jens Uhlig, MD, Dietger Niederwieser, MD

Blood (2005) 106 (11): 5154.

https://doi.org/10.1182/blood.V106.11.5154.5154

Published: 2005

NARROW

Phase II Study of Stimulation of Healthy Sibling Donors with Single-Shot Pegfilgrastim - Update (EUDRACT Nr: 2005-004971-39)

Reduction of Immunosuppression after Disease-Specific Donor Cell Chimerism Decrease Can Prevent Hematological Relapse Following Allogeneic Stem Cell Transplantation after Non-Myeloablative (NMA) Conditioning — Results of a Prospective Phase II Study. Eudract #: 2007-002420-15

Unsupervised Cluster Analysis of Antigen Expression Patterns Identifies Subgroups with Distinct Biological and Clinical Features in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Inclusion of Plerixafor Increases the Efficacy of Stem Cell Harvesting in Poorly Mobilizing Patients with Multiple Myeloma and Lymphoma

Low Level BCR-ABL Mutations and Response to Treatment: A Substudy of the ENEST1st Trial

Reduced Intensity Conditioning Allogeneic Haematopoietic Stem Cell Transplantation - a Treatment Option in Elderly or Comorbid Patients with Acute Lymphatic Leukemia

Successful Stem Cell Mobilization and Autologous Stem Cell Transplantation after Pretreatment Consisting of Bendamustine, Prednisone and Bortezomib (BPV) in 35 Patients with Newly Diagnosed/Untreated Multiple Myeloma

Low Level BCR-ABL Mutations Below the Detection Limit of Current Standard Screening Techniques Occur Predominantly in the CD34+ Progenitor Cell Compartment in Chronic Phase CML Patients At Diagnosis. A Substudy of the ENEST1st Trial

Impact of Bendamustine Pretreatment on Stem Cell Mobilization and Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Adverse Immunologic, Cytogenetic, and Molecular Features of AML in Elderly Patients Could Be Overcome by Allogeneic Hematopoietic Cell Transplantation Following Reduced Intensity Conditioning

Successful Mobilization of Peripheral Blood Stem Cells After Intensive Bendamustine Pre-Treatment In Patients with Multiple Myeloma

The Ratio of Pre-Transplant Serum Ferritin to the Units of Blood Transfused and Not Serum Hepcidin Strongly Correlates with Outcome After Allogeneic Hematopoietic Cell Transplantation In Patients with AML and MDS.

Elevated Serum Hepcidin in Patients with AML Prior to and After Allogeneic Hematopoietic Cell Transplantation Does Not Correlate with Transfusional Body Iron, HFE Genotype or Graft Versus Host Disease and May Protect From Excessive Parenchymal Iron Loading.

Mobilization of Allogeneic Peripheral Blood Stem Cells in Family Donors with Single-Dose Pegfilgrastim.

Factors Influencing Relapse after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

Monitoring of Incipient Haematological Relapse by CD34 + Donor Chimerism Determination in Patients with Acute Myelogenous Leukaemia and Myelodysplastic Syndrome after Allogeneic Hematopoietic Cell Transplantation (HCT) Following Low Dose TBI-Based Conditioning Regimens.

Donor CD34+ Cell Chimerism at Day 28 and Chronic Graft-Versus-Host Disease (GvHD) but Not High-Risk Cytogenetics Influence Outcome of Allogeneic Hematopoetic Cell Transplantation (HCT) Following Reduced Intensity Conditioning (RIC) in Patients with AML and MDS.

CD34 + Donor Chimerism and Wilms Tumor Gene 1 (WT1) Expression Provide an Early Indication of Relapse in Patients with Acute Leukemias and MDS after Hematopoietic Cell Transplantation (HCT) with Reduced-Intensity Conditioning.

Loss of Heterozygosity (LOH) for HumACTBP2 (SE33) Is Detected in Philadelphia (Ph)-Positive and Ph-Negative Hematopoietic Cells of Some Patients with Ph-Positive CML.

Bendamustine in Combination with Thalidomide and Prednisolone (BPT) in Patients with Refractory or Relapsed Multiple Myeloma after Conventional Chemotherapy: Final Results of a Phase I Study.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only